GHO Capital
GHO Capital (Global Healthcare Opportunities) is a London-based specialist healthcare investment firm founded in 2014, regulated by the FCA under firm reference number 1044842. It invests in companies with a European presence and global potential across outsourced pharma services, PharmaBio, MedTech and patient services, deploying capital through discrete buyout and growth funds. The firm closed Fund IV at over EUR 2.5bn in 2025, bringing assets under management to around EUR 9bn and making it the largest healthcare specialist private equity firm headquartered in Europe.
Key facts
Recent exits
Coverage notes
4 funds tracked, 22 portfolio companies (15 active · 7 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
22 companiesFunds & portfolio
Every fund GHO Capital has raised, with its portfolio companies. Hand-checked from public filings.
GHO Capital IV LPBuyout2025 · 1yr€2.5B3 active
Unrealized
3 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech |  US | 2025 | |
| MedTech |  Germany | 2025 | |
| HealthTech | US | 2025 |
US· Entry 2025Germany· Entry 2025US· Entry 2025GHO Capital III LPBuyout2021 · 5yr€2.0B7 active · 1 realized
Unrealized
7 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Pharma | US | 2022 | |
| Business Services | US | 2021 | |
| HealthTech | US | 2021 | |
| Biotech |  UK | 2021 | |
| MedTech | Germany | 2022 | |
| HealthTech | US | 2022 | |
| HealthTech | US | 2021 |
US· Entry 2022US· Entry 2021US· Entry 2021UK· Entry 2021Germany· Entry 2022US· Entry 2022US· Entry 2021Realized
1 exit| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| MedTech | US | 2021 | 2026 | Trade Sale | – |
GHO Capital Fund II LPBuyout2019 · 7yr€975M3 active · 1 realized
Belgium
PortugalGHO Capital Fund I LPBuyout2015 · 11yr€660M2 active · 5 realized
Unrealized
2 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Healthcare | Germany | 2018 | |
| Healthcare | UK | 2015 |
Germany· Entry 2018UK· Entry 2015Realized
5 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Biotech | US | 2018 | 2021 | Trade Sale | – | ||
| Biotech | Canada | 2016 | 2019 | Secondary | – | ||
| Healthcare | US | 2015 | 2021 | Trade Sale | – | ||
| Pharma | UK | 2015 | 2019 | Secondary | – | ||
| Pharma | UK | 2016 | 2026 | Trade Sale | – |
Saved GPs appear in your watchlist, one click from your workspace.
About GHO Capital
GHO Capital is an alternative investment platform with capital deployed across 4 active fund vehicles, headquartered in London. The firm deploys capital across European mid and small-cap businesses spanning healthcare and industrials.
Investment thesis
The platform combines complementary investment strategies, deploying capital across healthcare and industrials businesses in the United Kingdom and broader European market. Multi-strategy capital deployment enables flexibility across the business lifecycle, with the partnership culture supporting management teams through growth, transmission and selective M&A across multiple fund vintages and asset classes.
Recent activity
Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 4 fund vehicles, 14 active portfolio companies and 0 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
United Kingdom·€11.0B
United Kingdom·€11.0B
United Kingdom·€7.0B
United Kingdom·€7.0B
United Kingdom·€6.4B
United Kingdom·€11.7B
United Kingdom·€12.7B
United Kingdom·€4.8B
United Kingdom·€4.4B
United Kingdom·€4.4B
United Kingdom·€13.8B
United Kingdom·€4.1BGet the full picture on GHO Capital.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in